Bacil Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	May '25 May 13, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	596	610	86	32	34	18	Upgrade
Market Cap Growth	607.73%	607.73%	166.97%	-4.36%	83.65%	89.09%	Upgrade
Enterprise Value	569	610	83	28	33	17	Upgrade
Last Close Price	41.55	42.49	14.63	5.48	5.73	3.12	Upgrade
PE Ratio	60.22	150.92	-	-	-	-	Upgrade
PS Ratio	90.17	92.21	-	-	-	-	Upgrade
PB Ratio	2.35	2.40	7.10	2.94	2.76	1.32	Upgrade
P/TBV Ratio	2.35	2.40	7.10	2.94	2.76	1.32	Upgrade
P/FCF Ratio	-	152.16	-	-	-	-	Upgrade
P/OCF Ratio	148.79	152.16	-	-	-	-	Upgrade
EV/Sales Ratio	86.10	92.28	-	-	-	-	Upgrade
EV/EBITDA Ratio	139.46	149.48	-	-	-	-	Upgrade
EV/EBIT Ratio	139.70	149.74	-	-	-	-	Upgrade
EV/FCF Ratio	-	152.28	-	-	-	-	Upgrade
Debt / Equity Ratio	0.01	0.01	0.08	0.02	0.03	0.13	Upgrade
Debt / EBITDA Ratio	0.40	0.40	-	-	-	-	Upgrade
Debt / FCF Ratio	0.41	0.41	-	-	-	-	Upgrade
Asset Turnover	0.05	0.05	-	-	-	-	Upgrade
Quick Ratio	16.92	16.92	0.37	7.87	6.49	0.09	Upgrade
Current Ratio	17.21	17.21	0.46	8.19	6.69	0.11	Upgrade
Return on Equity (ROE)	3.03%	3.03%	-5.11%	-8.77%	-295.12%	-17.22%	Upgrade
Return on Assets (ROA)	1.89%	1.89%	-9.62%	-9.37%	-3.70%	-2.54%	Upgrade
Return on Capital (ROIC)	1.89%	1.89%	-9.71%	-9.45%	-7.02%	-6.67%	Upgrade
Return on Capital Employed (ROCE)	1.60%	1.60%	-	-	-	-	Upgrade
Earnings Yield	0.68%	0.66%	-0.69%	-3.16%	-114.37%	-13.02%	Upgrade
FCF Yield	-	0.66%	-0.03%	-4.57%	-118.79%	-21.66%	Upgrade
Buyback Yield / Dilution	0.82%	0.82%	1.48%	-1.71%	-0.99%	0.04%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.